Capital clarity: Questions to ask before raising

Venture capital is a common source of funding for startups, but many founders question whether it's the right choice for their business. This is particularly relevant in health technology, where long sales cycles and cautious buyers can complicate the impact of outside capital. Before raising venture capital, founders should consider several key questions to ensure the decision aligns with their long-term goals.

Firstly, founders should determine where they envision the company to be in 10 years. This long-term perspective helps gauge whether venture capital is necessary to reach the next major milestone or if customer revenue could better fund that progress. Secondly, founders need to decide how much equity they are willing to relinquish and whether the additional funding will force the company down a particular path with specific owners, milestones, and timelines.

The size of the target market is also crucial in determining the appropriate amount of capital. Early rounds of funding are often less risky as they focus on testing product-market fit, while later rounds can force a company to outgrow its market, creating unnecessary risk. Additionally, the size of the venture fund a company accepts can significantly influence the business's growth trajectory, burn rate, and eventual exit value.

Larger funds require higher growth rates, more significant burn rates, and more ambitious exit targets, while smaller funds can provide more patient capital suited to a company's needs.

In healthcare, revenue funding can be a safer and more efficient source of financing, particularly when customer revenue covers costs, the product has high gross margins, and the sales process is repeatable. Comparing the value of equity from a funding round with the cost of achieving the same milestones through revenue funding can provide a clear decision point.

Other alternative financing options include bank loans, revenue-based financing, grants, and partnerships with larger companies. These alternatives allow startups to scale without diluting equity, but it's essential for each founder to evaluate which option best suits their business.

As the venture capital landscape becomes more concentrated, Seed-stage founders face increased pressure to demonstrate traction and growth. This shift in the market demands greater alignment of capital with a company's specific needs and long-term goals. Ultimately, founders must weigh the potential benefits and risks of venture capital against alternative financing methods, ensuring their decision aligns with the company's vision and future success.